Champions oncology, inc. (CSBR)
Income statement / Quarterly
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Oct'14Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Jul'11Apr'11Jan'11Oct'10Jul'10
Oncology services revenue

9,012

-

-

-

6,430

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Oncology services revenue

-

7,625

6,737

-

-

6,693

6,225

-

5,082

5,203

5,033

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating revenue

-

-

-

-

-

-

-

-

-

-

5,033

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Personalized oncology solutions

-

-

-

-

-

-

-

-

-

-

-

14,056

347

497

511

585

416

486

485

417

453

452

341

429

590

623

622

540

473

459

918

492

649

590

601

566

1,419

288

1,109

Translational oncology solutions

-

-

-

-

-

-

-

-

-

-

-

-

3,218

3,960

3,159

2,252

2,136

2,485

2,337

2,823

1,376

1,430

1,571

2,028

3,100

1,760

2,398

1,302

2,444

999

1,188

886

1,747

1,151

1,033

978

1,386

645

491

Total operating revenue

-

-

-

-

-

-

-

-

-

-

-

3,719

3,565

4,457

3,670

2,837

2,552

2,971

2,822

3,240

1,829

1,882

1,912

2,457

3,690

2,383

3,020

1,842

2,917

1,458

2,106

1,378

2,396

1,741

1,634

1,544

2,805

933

1,600

Costs and operating expenses:
Cost of oncology services

4,325

3,881

3,752

-

3,429

3,451

3,083

-

2,473

2,653

2,642

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of oncology services

-

-

-

-

-

-

-

-

-

-

-

8,535

320

374

474

394

479

568

661

543

674

759

757

592

614

732

793

642

676

582

772

884

528

461

483

452

725

164

324

Cost of translational oncology solutions

-

-

-

-

-

-

-

-

-

-

-

-

2,086

1,829

2,049

1,902

1,627

1,443

1,612

1,674

1,301

960

965

948

1,008

698

878

916

566

475

699

703

801

620

419

541

688

395

222

Research and development

1,391

1,341

1,303

1,248

1,269

1,193

1,088

1,123

1,045

1,115

1,118

1,076

998

1,008

1,211

1,176

999

919

1,100

1,080

1,093

1,249

1,423

651

535

677

402

505

592

436

387

458

930

1,008

541

884

434

673

919

Sales and marketing

1,307

977

870

919

879

740

518

709

627

551

683

893

726

717

925

803

779

834

1,029

952

1,094

1,203

1,034

994

821

698

642

618

658

680

709

966

623

651

688

632

239

80

134

General and administrative

1,556

1,135

1,426

1,366

1,223

1,034

1,055

904

1,004

954

1,209

1,571

836

1,022

1,534

1,115

1,041

1,700

1,317

1,415

1,086

1,377

1,462

1,657

2,120

1,279

1,071

1,147

1,145

1,201

1,138

976

1,287

1,470

1,717

1,866

1,505

636

604

Total costs and operating expenses

8,579

7,334

7,351

7,835

6,800

6,418

5,744

5,521

5,149

5,273

5,652

6,111

4,966

4,950

6,193

5,390

4,925

5,464

5,719

5,664

5,248

5,548

5,641

4,842

5,098

4,084

3,786

3,828

3,637

3,374

3,705

3,987

4,169

4,210

3,848

4,375

3,591

1,948

2,203

Income (loss) from operations

433

291

-614

-116

-370

275

481

-598

-67

-70

-619

-2,392

-1,401

-493

-2,523

-2,553

-2,373

-2,493

-2,897

-2,424

-3,419

-3,666

-3,729

-2,385

-1,408

-1,701

-766

-1,986

-720

-1,916

-1,599

-2,609

-1,773

-2,469

-2,214

-2,831

-786

-1,015

-603

Other income (expense):
Grant income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

367

961

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-420

621

625

155

236

846

-585

-1,462

-52

-255

-52

285

64

66

110

177

-36

0

0

0

Other income (expense)

-14

27

-12

-34

1

-7

1

-18

-7

-13

-51

-23

-8

-16

-9

-6

-8

-14

-10

-168

-6

-27

31

-127

-7

-29

-1

-4

-10

-5

-6

-

-12

-

-

-

-

-

-

Other (expense) income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

0

-1

4

0

12

Total other expense (income)

-

-

-12

-

-

-

1

-18

-7

-13

-51

-23

-8

-16

-9

-6

-8

-14

-10

-1,174

615

598

186

109

839

-614

-1,463

-56

-265

-57

279

51

54

120

177

100

371

961

12

Income (loss) before provision for income taxes

419

318

-626

-150

-369

268

482

-616

-74

-83

-670

-2,415

-1,409

-509

-2,532

-2,559

-2,381

-2,507

-2,907

-3,598

-2,804

-3,068

-3,543

-2,276

-569

-2,315

-2,229

-2,042

-985

-1,973

-1,320

-2,558

-1,719

-2,349

-2,037

-2,731

-415

-54

-591

Income Tax Expense (Benefit)

12

11

15

102

0

1

0

16

2

11

4

10

0

-5

14

14

31

41

6

100

12

10

5

6

5

3

3

1

5

1

3

-

0

-

0

11

0

0

0

Provision for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Net Income (Loss) Attributable to Parent

407

307

-641

-252

-369

267

482

-632

-76

-94

-674

-2,424

-1,408

-504

-2,546

-2,572

-2,412

-2,548

-2,913

-3,697

-2,816

-3,078

-3,548

-2,282

-574

-2,318

-2,232

-2,043

-990

-1,974

-1,323

-2,556

-1,719

-2,349

-2,037

-2,742

-415

-54

-591

Net income (loss) per common share outstanding
Net loss per common share outstanding, basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-0.20

-0.13

-0.05

-0.26

-0.30

-0.28

-0.29

-0.33

-

-

-

-

-

-

-

-0.03

-0.03

-0.02

-0.04

-0.03

-0.06

-0.04

-0.05

-0.04

-0.08

-0.01

0.00

-0.02

Net income (loss) per common share outstanding, basic (in dollars per share)

0.03

0.03

-0.06

-0.02

-0.03

0.02

0.04

-0.05

-0.01

-0.01

-0.06

-

-

-

-

-

-

-

-

-

-0.51

-0.05

-0.64

-

-0.01

-0.03

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per common share outstanding, diluted (in dollars per share)

0.03

0.02

-0.06

-0.02

-0.03

0.02

0.04

-0.05

-0.01

-0.01

-0.06

-

-

-

-

-

-

-

-

-

-0.61

-0.05

-0.64

-

-0.02

-0.03

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding
Weighted average common shares outstanding, basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

10,967

10,967

10,967

9,835

8,674

8,702

8,702

8,702

-

-

-

-

-

-

-

66,852,100

-93,985,549

47,737

47,079,000

47,067,000

47,312

46,738

46,790

46,420

-

-

-

-

Weighted average common shares outstanding, basic (in shares)

11,752

11,619

11,619

11,561

11,508

11,278

11,012

10,999

10,994

10,988

10,982

-

-

-

-

-

-

-

-

-

5,574

66,887

5,573

-

66,867

66,863

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding, diluted (in shares)

13,673

12,964

11,619

18,221

11,508

14,037

12,618

10,999

10,994

10,988

10,982

-

-

-

-

-

-

-

-

-

5,603

67,855

5,819

-

66,867

66,863

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding, including redeemable common stock, basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35,664

-

-

Weighted average common shares outstanding, including redeemable common stock, basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35,677,000

33,774